June 13, 2022 — Many sections of the non-coding region of the human genome play a key role in regulating gene activity. But the relationship between non-coding mutations and cancer risk has been a mystery. New research sheds light on that mystery, providing clues that may link mutations to epigenetic changes, and may point to potential drug targets to reduce risk …Read More
News Flash:
- Use of acid reflux drugs linked to higher risk of migraine-Click Here
- Food in sight? The liver is ready!-Click Here
- Tumor cells evade the immune system early on: Newly discovered mechanism could significantly improve cancer immunotherapies-Click Here
- Solving the riddle of the sphingolipids in coronary artery disease-Click Here
- Breakthrough rice bran nanoparticles show promise as affordable and targeted anticancer agent-Click Here
- 3 in 5 parents play short order cook for young children who don’t like family meal-Click Here
- Eye-opener: Pupils enlarge when people focus on tasks-Click Here
- Genetically engineering a treatment for incurable brain tumors-Click Here
- New research defines specific genomic changes associated with the transmissibility of the monkeypox virus-Click Here
- Shoe technology reduces risk of diabetic foot ulcers-Click Here
